Connor, K.M.
~ 7700  results:
Search for persons X
?
1

Macrophage- and RIP3-dependent inflammasome activation exac..:

Kataoka, K ; Matsumoto, H ; Kaneko, H...
Cell Death & Disease.  6 (2015)  4 - p. e1731-e1731 , 2015
 
?
2

S.27.02 Orexin receptor antagonists and insomnia treatment:..:

Gotter, A.L. ; Coleman, P.J. ; Kuduk, S.D....
European Neuropsychopharmacology.  24 (2014)  - p. S144-S145 , 2014
 
?
 
?
5

Matrigel cytometry: A novel method for quantifying angiogen..:

Adini, A. ; Fainaru, O. ; Udagawa, T....
Journal of Immunological Methods.  342 (2009)  1-2 - p. 78-81 , 2009
 
?
 
?
8

A controlled trial of combined sertraline and prolonged exp..:

Connor, K.M. ; Rothbaum, B. ; Foa, E.B....
European Neuropsychopharmacology.  12 (2002)  - p. 335 , 2002
 
?
 
?
10

Mirtazapine in posttraumatic stress disorder: Results of a ..:

Connor, K.M. ; Davidson, J.R.T. ; Weisler, R.H...
European Neuropsychopharmacology.  12 (2002)  - p. 334-335 , 2002
 
?
11

A placebo-controlled study of Kava kava in generalized anxi..:

Connor, K.M. ; Davidson, J.R.T.
International Clinical Psychopharmacology.  17 (2002)  4 - p. 185-188 , 2002
 
?
12

SPRINT: a brief global assessment of post-traumatic stress ..:

Connor, K. M. ; Davidson, J. R.T.
International Clinical Psychopharmacology.  16 (2001)  5 - p. 279-284 , 2001
 
?
13

Natural course of PTSD and its long-term treatment:

Davidson, J.R.T. ; Connor, K.M.
European Neuropsychopharmacology.  11 (2001)  - p. S148-S149 , 2001
 
?
14

Olanzapine in the treatment of post-traumatic stress disord..:

Butterfield, M. I. ; Becker, M. E. ; Connor, K. M....
International Clinical Psychopharmacology.  16 (2001)  4 - p. 197-203 , 2001
 
?
15

Symptom-specific effects of fluoxetine in post-traumatic st..:

Meltzer-Brody, S. ; Connor, K. M. ; Churchill, E..
International Clinical Psychopharmacology.  15 (2000)  4 - p. 227-231 , 2000
 
1-15